Global Heart Pump Devices Market Comprehensive Study Explores Huge Growth in Future and Competitive Strategies - Abbott, Boston Scientific, Boston Scientific Cardiology, CryoLife Inc., Medtronic, Edwards Lifesciences, Symetis, Braile Biomédica

The Global Heart Pump Devices Market report highlights important trends and dynamics, including limitations, drivers and opportunities, affecting market growth. A number of research tools have been used to provide a precise understanding of this market, such as Porter's five-force analysis and SWOT analysis. The report provides data on the technological advances that are expected to occur in the coming years or are currently taking place. The report examines the imminent Heart Pump Devices Market in North America, Europe, Asia-Pacific (APAC), the Middle East and Africa and Latin America in regional terms. In addition, the countries that generate high revenue in these regions have also been examined in these countries with comprehensive coverage and innovation. The Global Heart Pump Devices Market Study integrates market modules development conditions and definition. The global market is classified by type, type of product, type of material, application, vertical application and end-use applications. The market was categorized in the next piece in terms of presentation. In this statistical survey research report, the presentation segments of the global market are also mentioned.

According to the latest research, global demand for Heart Pump Device Market was valued at approximately USD 1.57 billion in 2017 and expected to reach USD 6.22 billion in 2025 with growing at a healthy CAGR of 18.8%.

FREE | Sample Report Available at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-heart-pump-device-market

Major Drivers of Heart Pump Device Market

Prominent factors driving the growth of this market consist of increasing incidence of cardiac disease, rapid advancement in surgical technique in VAD implantation, increasing popularity of minimal invasive surgical procedures in cardiology, regulatory approval of heart pump devices are fuel the growth of heart pump devices market.

Increasing Incidence of Cardiac Diseases:

According to Health Data Government, world population from past increase 7 billion and increasing the number of geriatric population. So the number of death from cardiovascular diseases is also increasing. As per the European Society of Cardiology in 2014, approximately 26 million people in all over world suffering from heart failure. Cardiac diseases such as heart attacks, strokes and other circulatory disease is the major cause of premature death in the world.

Increasing regulatory approval and reimbursement procedure of heart pump devices:

Regulatory approval is defined as that approvals by government pricing or health authorities in a country (including FDA and EMEA), product and establishment licenses, registrations or authorizations of any federal, state or local regulatory agency, department, bureau or other governmental entity, in each case. These regulatory approvals are necessary for the commercial manufacture, usage, storage, importation, export, transport or sale of collaboration products in a regulatory jurisdiction. Different countries have different regulatory body for medical device licensing. In India, cardiac implantable medical devices are listed under the classification of medical device rules with regulatory approval and registration by the CDSCO (Central Drug Standard Controller Organization).The CDSCO (Central Drug Standard Controller Organization) is govern by the Drug Controller General of India (DCGI).

About Key Players:

Abbott:

Abbott founded in 1888 and headquarters in Illinois, U.S., focuses on manufacturing products for diagnostics, medical devices, nutrition and branded generic pharmaceuticals. It operates its business through Established Pharmaceuticals, Nutritionals, Diagnostics, Cardiovascular and Neuromodulation and Others. It offers heart pumps products through its cardiovascular and neuromodulation.

The company has its presence in U.S., China, Germany, Japan, India, The Netherland, Switzerland, Russia, France, Brazil, Italy, U.K., Colombia, Canada, Vietnam and others. It has its subsidiaries worldwide such as Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd (India), Thoratec Corporation (U.S.) and others.

• In January 2017, Abbott (U.S.) acquired ST. JUDE MEDICAL (U.S.). This acquisition expanded Abbott (U.S.) opportunities for future growth and development of strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals.

Getinge AB:

Getinge AB, founded in 1904 and based in Sweden. It is involved in designing, manufacturing and marketing of equipment and systems for healthcare and life sciences. It operates its business through acute care therapies and surgical workflows. It offers heart pump devices through its subsidiary Maquet (Germany). The company has its presence in North America, South America, Asia Pacific, Europe, Middle East and Africa.

• In Feburary 2014, Getinge AB (Sweden) acquired Pulsion Medical Systems (Germany). This acquisition has expanded business of the company.

Get Instant 25% Off on this ready report, Mail Us at Sopan.gedam@databridgemarketresearch.com

TABLE OF CONTENTS GLOBAL HEART PUMP DEVICES MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL HEART PUMP DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 DBMR MARKET CHALLENGE MATRIX
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING INCIDENCE OF CARDIAC DISEASES
3.1.2 INCREASING REGULATORY APPROVAL AND REIMBURSEMENT PROCEDURE OF HEART PUMP DEVICES
3.1.3 RAPID ADVANCEMENT IN SURGICAL TECHNIQUE FOR VAD IMPLANTATION
3.1.4 INCREASING POPULARITY OF MINIMALLY INVASIVE SURGICAL PROCEDURES IN CARDIOLOGY

3.2 RESTRAINTS

3.2.1 HIGHT COST OF PROCESS AND PRODUCT

3.3 OPPORTUNITIES

3.3.1 EMERGING COUNTRIES

3.4 CHALLENGES

3.4.1 COMPLICATIONS RELATED TO LVAD

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL HEART PUMP DEVICES MARKET, BY PRODUCTS

6.1 OVERVIEW

6.2 INTRA-AORTIC BALLOON PUMPS

6.3 VENTRICULAR ASSIST DEVICE

6.3.1.1 LEFT VENTRICULAR ASSIST DEVICES
6.3.1.2 PERCUTANEOUS VENTRICULAR ASSIST DEVICES
6.3.1.3 RIGHT VENTRICULAR ASSIST DEVICES
6.3.1.4 BI-VENTRICULAR ASSIST DEVICES
6.3.1.5 OTHERS

6.4 TOTAL ARTIFICIAL HEART

7 GLOBAL HEART PUMP DEVICES MARKET, BY TYPE

7.1 OVERVIEW
7.2 IMPLANTABLE HEART PUMP DEVICES
7.3 EXTRACORPOREAL HEART PUMP DEVICES

8 GLOBAL HEART PUMP DEVICES MARKET, BY THERAPY

8.1 OVERVIEW
8.2 BRIDGE-TO-TRANSPLANT
8.3 DESTINATION THERAPY
8.4 BRIDGE-TO-CANDIDACY (BTC)
8.5 OTHERS

9 GLOBAL HEART PUMP DEVICES MARKET, BY END USER

9.1 OVERVIEW
9.2 HOSPITALS
9.3 AMBULATORY SURGICAL CENTERS
9.4 CLINICS
9.5 RESEARCH INSTITUTES

10 GLOBAL HEART PUMP DEVICES MARKET, BY GEOGRAPHY

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO

10.3 EUROPE

10.3.1 GERMANY
10.3.2 U.K.
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 RUSSIA
10.3.7 SWITZERLAND
10.3.8 BELGIUM
10.3.9 NETHERLANDS
10.3.10 TURKEY
10.3.11 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 MALAYSIA
10.4.7 THAILAND
10.4.8 SINGAPORE
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA-PACIFIC

10.5 SOUTH AMERICA

10.5.1 BRAZIL
10.5.2 REST OF SOUTH AMERICA

10.6 MIDDLE EAST & AFRICA

10.6.1 SOUTH AFRICA
10.6.2 REST OF MIDDLE EAST& AFRICA

11 GLOBAL HEART PUMP DEVICES MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 COMPANY PROFILE

13 RELATED REPORTS

FREE | TOC Available at https://databridgemarketresearch.com/toc/?dbmr=global-heart-pump-device-market

Major Business Entities Covered in this Report

• Abbott,
• Abiomed,
• Medtronic,
• Getinge,
• Maquet Getinge Group,
• Syncardia Systems,
• Teleflex,
• HeartWare International Inc.,
• Berlin Heart GmbH,
• Getinge AB,
• Fresenius Medical Care,
• Syncardia Systems,
• Reliantheart,
• Terumo Europe NV,
• Berlin Heart,
• Jarvik Heart,
• Cardiacassist,
• Thoratec Corporation,
• Jarvik Heart, Inc. among others.

Read More About This Report at https://databridgemarketresearch.com/reports/global-heart-pump-device-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Sopan gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.